Therefore, the aim of this study is to determine the effect of letrozole (anti-aromatase) and STX-64 (anti-sulfatase) in canine and human inflammatory breast cancer cell lines and xenografts. This evidence concerns the gene CYP19A1 and inflammatory breast carcinoma.